1. HBW Insight
  2. >>Wellness
  3. >>Innovation & IP

Nestlé Developing Microbiome-Based Supplements with Dutch Partner

 
• By Tom Gallen

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

Bacteria cells
• Source: Shutterstock

Nestle Health Science SA has entered into a strategic collaboration with Netherlands-based Caelus Health to develop microbiome-based food supplements for the prevention and early treatment of cardio-metabolic diseases.

Under the terms of a global development and option agreement signed by both firms, Nestlé has agreed to fund Caelus’ efforts to further pursue the preclinical and clinical development of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation & IP

More from Wellness

US FDA Supplement Office Chief Eyes ‘Movement’ This Year On NDI Notifications Final Guidance

 
• By Malcolm Spicer

“We've made some progress and really hope to see some movement as we move forward this year,” says FDA Office of Dietary Supplement Programs director Cara Welch.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By Tom Gallen

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By Tom Gallen

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.